Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies

Nanomedicine efficacy in a clinical setting depends on the pharmacological properties of the therapeutic nanoparticles. Here, the authors exemplify an accelerated translational strategy from small-scale screening to clinical scale-up for an orally-dosed aqueous paediatric HIV nanomedicine.

Guardado en:

Detalles Bibliográficos
Autores principales:	Marco Giardiello, Neill J. Liptrott, Tom O. McDonald, Darren Moss, Marco Siccardi, Phil Martin, Darren Smith, Rohan Gurjar, Steve P. Rannard, Andrew Owen
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2016
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/26c00fb46cdc4d1980acae4ffeece5f0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:26c00fb46cdc4d1980acae4ffeece5f0
record_format	dspace
spelling	oai:doaj.org-article:26c00fb46cdc4d1980acae4ffeece5f02021-12-02T15:34:59ZAccelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies10.1038/ncomms131842041-1723https://doaj.org/article/26c00fb46cdc4d1980acae4ffeece5f02016-10-01T00:00:00Zhttps://doi.org/10.1038/ncomms13184https://doaj.org/toc/2041-1723Nanomedicine efficacy in a clinical setting depends on the pharmacological properties of the therapeutic nanoparticles. Here, the authors exemplify an accelerated translational strategy from small-scale screening to clinical scale-up for an orally-dosed aqueous paediatric HIV nanomedicine.Marco GiardielloNeill J. LiptrottTom O. McDonaldDarren MossMarco SiccardiPhil MartinDarren SmithRohan GurjarSteve P. RannardAndrew OwenNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Marco Giardiello Neill J. Liptrott Tom O. McDonald Darren Moss Marco Siccardi Phil Martin Darren Smith Rohan Gurjar Steve P. Rannard Andrew Owen Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
description	Nanomedicine efficacy in a clinical setting depends on the pharmacological properties of the therapeutic nanoparticles. Here, the authors exemplify an accelerated translational strategy from small-scale screening to clinical scale-up for an orally-dosed aqueous paediatric HIV nanomedicine.
format	article
author	Marco Giardiello Neill J. Liptrott Tom O. McDonald Darren Moss Marco Siccardi Phil Martin Darren Smith Rohan Gurjar Steve P. Rannard Andrew Owen
author_facet	Marco Giardiello Neill J. Liptrott Tom O. McDonald Darren Moss Marco Siccardi Phil Martin Darren Smith Rohan Gurjar Steve P. Rannard Andrew Owen
author_sort	Marco Giardiello
title	Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
title_short	Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
title_full	Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
title_fullStr	Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
title_full_unstemmed	Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
title_sort	accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric hiv nanotherapies
publisher	Nature Portfolio
publishDate	2016
url	https://doaj.org/article/26c00fb46cdc4d1980acae4ffeece5f0
work_keys_str_mv	AT marcogiardiello acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT neilljliptrott acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT tomomcdonald acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT darrenmoss acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT marcosiccardi acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT philmartin acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT darrensmith acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT rohangurjar acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT steveprannard acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies AT andrewowen acceleratedoralnanomedicinediscoveryfromminiaturizedscreeningtoclinicalproductionexemplifiedbypaediatrichivnanotherapies
_version_	1718386647023747072

Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies

Ejemplares similares